+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Soft Tissue Allografts Market 2021-2026

  • ID: 5359068
  • Report
  • June 2021
  • Region: Global
  • 149 Pages
  • BCC Research

FEATURED COMPANIES

  • Allosource Inc.
  • Arthrex Inc.
  • Cook Medical Inc.
  • Johnson & Johnson
  • Organogenesis Inc.
  • Straumann Holding Ag.

The global market for soft tissue allografts should grow from $5.1 billion in 2021 to $6.6 billion by 2026, at compound annual growth rate (CAGR) of 5.3% for the period of 2021-2026.

Report Scope

The report will provide details about the soft tissue allografts used in the treatment of dental disease, facial dental surgery, orthopedic surgery, and other surgical processes. It will also highlight the current and future market potentiality of soft tissue allografts with detailed analysis of the competitive environment. Drivers, restraints, opportunities, pricing analysis, prevalence or incidence dental diseases, orthopedic surgeries using allografts, and the regulatory scenario assessment will be covered in the report. The report includes a market projection for 2026, and a market share analysis for key players.

This report segments the market for soft tissue allografts based on products, applications, and geography. Product types are cartilage allografts, tendon allografts, meniscus allografts, dental allografts, collagen allografts, and amniotic allografts. Applications are orthopedic, dentistry, wound care, and others.

By geographical region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries, and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2020 as the base year, with estimates for 2021 and forecast value for 2026.

Tooth loss is very common and can happen as a result of disease or trauma, and the use of dental implants to provide support for the replacement of missing teeth has a long and multifaceted history. Statistics by the American Association of Oral and Maxillofacial Surgeons show that 69% of adults ages 35 to 44 have lost at least one permanent tooth to an accident, gum disease, a failed root canal, or tooth decay. Furthermore, by age 74, 26% of adults have lost all of their permanent teeth. Research on dental implant designs, materials and techniques has increased in the past few years and is expected to expand in the future due to the recent growth of the market for dental implants and the rise in demand for cosmetic dentistry, which points to increased demand for soft tissue allografts.

The increase in life expectancy and oral hygiene concerns have increased total dental visits; and additionally, the aging population plays a pivotal role in driving the demand for soft tissue allografts.

The report also includes a discussion of the major drivers and global dynamics, along with the political, economic, social, and technological factors that will have an impact on the market. Market estimates and forecast figures are provided for all major market segments. A discussion of the major players is included in the competitive landscape section, which provides trends in product launches, collaborations, mergers and acquisitions, and other agreements.

The Report Includes:

  • 31 data tables and 22 additional tables
  • An updated review and in-depth analysis of the global market for soft tissue allografts
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Estimation of current market size and revenue forecast for global soft tissue allografts market, and corresponding market share analysis by product type, application and geography
  • Highlights of current and future market potential for soft tissue allografts with clinical applications in the treatment of dental disease, facial dental surgery, orthopedic surgery, and other surgical process
  • Discussion of market dynamics, industry structure, pricing analysis, prevalence or incidence dental diseases, regulatory scenario, and penetration of technologies within the biotech industry
  • Coverage of country specific data and analysis for the U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Brazil, Argentina, China, Japan, India, Australia, GCC countries and South Africa within the regional segment
  • Impact analysis of COVID-19 pandemic on the growth of this market
  • Review of patents issued for tissue allograft products and therapies, new developments and potential markets for future developments
  • Discussion of market regulations and reimbursement policies for transplant procedures within/outside the U.S., and treatment in the EU countries
  • Insight into the growth development strategies of the major players operating within the global market and their key competitive landscape
  • Profile descriptions of the leading industry players, including Anika Therapeutics Inc., Cook Medical Inc., Johnson & Johnson, Straumann Holding AG, and Zimmer Biomet Holdings
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allosource Inc.
  • Arthrex Inc.
  • Cook Medical Inc.
  • Johnson & Johnson
  • Organogenesis Inc.
  • Straumann Holding Ag.

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Soft Tissue Allografts
  • General Overview of Joint Pain and Related Disorders
  • Osteoarthritis
  • Rheumatoid Arthritis
  • Wound Care
  • Organ Transplantation Alternatives
  • Trends in Soft Tissue Allografts Techniques and Their Alternatives
  • 3D Tissue Assembly
  • Nanotechnology for Tissue Regeneration
  • Innovation by Small Firms

Chapter 4 Market Dynamics

  • Market Drivers
  • Increase in the Incidence of Chronic Diseases
  • Rise in the Geriatric Population
  • Rising Awareness of Importance of Soft Tissues in Sport Injuries
  • New Therapeutic Pathways for Organ Transplantation and Their Alternatives
  • Market Restraints
  • Challenges in Government Approval Process for Orthopedic Devices
  • Soft Tissue Graft Lower Outcome Challenges
  • Market Opportunities
  • Growing Economic Benefits of Organ and Tissue Transplants
  • Increasing Demand for Cosmetic Dentistry

Chapter 5 Market Breakdown by Product

  • Orthopedic Alternatives
  • Global Market for Soft Tissue Allografts
  • Cartilage Allografts
  • Market Size and Forecast
  • Tendon Allografts
  • Market Size and Forecast
  • Meniscus Allografts
  • Market Size and Forecast
  • Dental Allografts
  • Market Size and Forecast
  • Collagen Allografts
  • Market Size and Forecast
  • Market Size and Forecast
  • Amniotic Allografts

Chapter 6 Market Breakdown by Application

  • Global Market for Soft Tissue Allografts
  • Orthopedic Applications
  • Market Size and Forecast
  • Dentistry
  • Market Size and Forecast
  • Wound Care
  • Market Size and Forecast
  • Other Applications
  • Market Size and Forecast

Chapter 7 Market Breakdown by Region

  • Global Market for Soft Tissue Allografts by Region
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia and New Zealand
  • Rest of Asia-Pacific
  • Latin America
  • Market Analysis
  • Brazil
  • Argentina
  • Rest of Latin American Countries
  • Middle East & Africa
  • Market Analysis
  • GCC Countries
  • South Africa
  • Rest of Middle Eastern & African Countries

Chapter 8 Impact of COVID-19

  • Introduction
  • Impact on Wound Care and Telehealth Management Program
  • Impact on Kidney Transplant Program
  • Donor Testing
  • COVID-19 in Transplant Recipients
  • Minimizing Infection Risk in Recipients
  • Future Perspectives

Chapter 9 Regulations and Reimbursement

  • Regulations in the U.S.
  • U.S. Federal Regulation of Human Tissue
  • History of Regulation in the U.S.
  • Regulations Outside the U.S.
  • Reimbursement in the U.S.
  • Organ Acquisition Costs
  • Reimbursement for Hospital Costs
  • Reimbursement for Physician Services
  • Reimbursement Outside the U.S.
  • Treatment in EU Countries

Chapter 10 Competitive Landscape

  • Market Share Analysis of Major Players
  • Mergers and Acquisitions
  • Key Developments
  • Mergers and Acquisitions in 2016-2018

Chapter 11 Company Profiles

  • Allosource Inc.
  • Anika Therapeutics Inc.
  • Arthrex Inc.
  • Biohorizons Iph
  • Biotissue Technologies Gmbh
  • Cook Medical Inc.
  • Globus Medical Inc.
  • Integra Lifesciences Corp.
  • Johnson & Johnson
  • Mimedx Group Inc.
  • Organogenesis Inc.
  • Seaspine
  • Straumann Holding Ag.
  • Zimmer Biomet Holdings

Chapter 12 Appendix: Acronyms

List of Tables
Summary Table: Global Market for Soft Tissue Allografts, by Product, Through 2026
Table 1: Cost of Hard-To-Heal Wounds
Table 2: MiMedx: Patent Portfolio
Table 3: Selected Global Commercial Opportunities for New Orthopedic Devices in the Future
Table 4: Indications for Bioartificial Liver Transplantation
Table 5: Global Market for Soft Tissue Allografts, by Product, Through 2026
Table 6: Cartilage and Soft Tissue Biologics and Biomaterials
Table 7: Global Market for Cartilage Allografts, by Region, Through 2026
Table 8: Global Market for Tendon Allografts, by Region, Through 2026
Table 9: Global Market for Meniscus Allografts, by Region, Through 2026
Table 10: Global Market for Dental Allografts, by Region, Through 2026
Table 11: Global Market for Collagen Allografts, by Region, Through 2026
Table 12: Global Market for Amniotic Allografts, by Region, Through 2026
Table 13: Global Market for Soft Tissue Allografts, by Application, Through 2026
Table 14: Global Market for Orthopedic Applications in Soft Tissue Allografts, by Region, Through 2026
Table 15: Global Market for Dentistry Applications in Soft Tissue Allografts, by Region, Through 2026
Table 16: Global Market for Wound Care Applications in Soft Tissue Allografts, by Region, Through 2026
Table 17: Global Market for Other Applications in the Soft Tissue Allografts, by Region, Through 2026
Table 18: Global Market for Soft Tissue Allografts, by Region, Through 2026
Table 19: North American Market for Soft Tissue Allografts, by Product, Through 2026
Table 20: North American Market for Soft Tissue Allografts, by Application, Through 2026
Table 21: North American Market for Soft Tissue Allografts, by Country, Through 2026
Table 22: European Market for Soft Tissue Allografts, by Product, Through 2026
Table 23: European Market for Soft Tissue Allografts, by Application, Through 2026
Table 24: European Market for Soft Tissue Allografts, by Country, Through 2026
Table 25: Examples of the Cost of Bone Damage Repair and Related Disorders in Europe
Table 26: Asia-Pacific Market for Soft Tissue Allografts, by Product, Through 2026
Table 27: Asia-Pacific Market for Soft Tissue Allografts, by Application, Through 2026
Table 28: Asia-Pacific Market for Soft Tissue Allografts, by Country, Through 2026
Table 29: Joint Replacement Procedures in Australia, 2017
Table 30: Latin American Market for Soft Tissue Allografts, by Product, Through 2026
Table 31: Latin American Market for Soft Tissue Allografts, by Application, Through 2026
Table 32: Latin American Market for Soft Tissue Allografts, by Country, Through 2026
Table 33: Middle Eastern & African Market for Soft Tissue Allografts, by Product, Through 2026
Table 34: Middle Eastern & African Market for Soft Tissue Allografts, by Application, Through 2026
Table 35: Registered Liver Transplantations (LT)/Kidney Transplantation in Middle East Countries, 2017
Table 36: Middle Eastern & African Market for Soft Tissue Allografts, by Country, Through 2026
Table 37: Number of Organ Transplant Procedures in Turkey, by Type of Organ, 2019-2020
Table 38: Selected Transplant Industry Acquisitions, 2010-2020
Table 39: AlloSource Inc.: Product Portfolio
Table 40: Anika Therapeutics Inc.: Product Portfolio
Table 41: BioHorizons: Products
Table 42: Cook Medical Inc.: Product Portfolio
Table 43: Globus Medical Inc.: Product Portfolio
Table 44: Integra: Product Portfolio
Table 45: Johnson & Johnson: Product Portfolio
Table 46: MiMedx Group Inc.: Product Portfolio
Table 47: Organogenesis Inc.: Product Portfolio
Table 48: SeaSpine: Product Portfolio
Table 49: Straumann Holding AG: Product Portfolio
Table 50: Zimmer Biomet Holdings: Product Portfolio
Table 51: Zimmer Biomet Holdings: Products
Table 52: Acronyms Used in This Report

List of Figures
Summary Figure: Global Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 1: Nanotechnology and Tissue Regeneration
Figure 2: Number of Elderly (≥ 65 Years) Receiving Kidney Transplantation in the U.S., 2014-2018
Figure 3: Number of Diabetes Patients Globally (20 to 79 Years of Age), 2000-2045
Figure 4: Percentage Distribution of Population Aged 65 and Above, by Region, 2015 and 2050
Figure 5: Number of Kidney Transplants, by Country, 2015
Figure 6: Patients on Waiting List vs. Transplants Performed in the U.S., by Organ, 2019
Figure 7: Global Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 8: Global Market for Cartilage Allografts, 2019-2026
Figure 9: Global Market for Cartilage Allografts, by Region, 2019-2026
Figure 10: Global Market for Tendon Allografts, 2019-2026
Figure 11: Global Market for Tendon Allografts, by Region, 2019-2026
Figure 12: Global Market for Meniscus Allografts, 2019-2026
Figure 13: Global Market for Meniscus Allografts, by Region, 2019-2026
Figure 14: Global Market for Dental Allografts, 2019-2026
Figure 15: Number of People Affected, by Common Dental Diseases, 2010
Figure 16: Global Market for Dental Allografts, by Region, 2019-2026
Figure 17: Global Market for Collagen Allografts, 2019-2026
Figure 18: Global Market for Collagen Allografts, by Region, 2019-2026
Figure 19: Percentages of Type III Collagen Found in Mammalian Dermis
Figure 20: Global Market for Amniotic Allografts, 2019-2026
Figure 21: Global Market for Amniotic Allografts, by Region, 2019-2026
Figure 22: Global Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 23: Global Market for Orthopedic Applications in Soft Tissue Allografts, 2019-2026
Figure 24: Global Market for Orthopedic Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 25: Global Market for Dentistry Applications in Soft Tissue Allografts, 2019-2026
Figure 26: Global Market for Dentistry Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 27: Global Market for Wound Care Applications in Soft Tissue Allografts, 2019-2026
Figure 28: Global Market for Wound Care Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 29: Global Market for Other Applications in Soft Tissue Allografts, 2019-2026
Figure 30: Global Market for Other Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 31: Global Market Shares of Soft Tissue Allografts, by Region, 2020
Figure 32: North American Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 33: North American Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 34: North American Market Shares for Soft Tissue Allografts, by Country, 2020
Figure 35: United States’ Market for Soft Tissue Allografts, 2019-2026
Figure 36: Canadian Market for Soft Tissue Allografts, 2019-2026
Figure 37: Mexican Market for Soft Tissue Allografts, 2019-2026
Figure 38: European Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 39: European Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 40: European Market Shares of Soft Tissue Allografts, by Country, 2020
Figure 41: German Market for Soft Tissue Allografts, 2019-2026
Figure 42: French Market for Soft Tissue Allografts, 2019-2026
Figure 43: U.K. Market for Soft Tissue Allografts, 2019-2026
Figure 44: Italian Market for Soft Tissue Allografts, 2019-2026
Figure 45: Spanish Market for Soft Tissue Allografts, 2019-2026
Figure 46: Rest of Europe’s Market for Soft Tissue Allografts, 2019-2026
Figure 47: Asia-Pacific Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 48: Asia-Pacific Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 49: Asia-Pacific Market Shares for Soft Tissue Allografts, by Country, 2020
Figure 50: Japanese Market for Soft Tissue Allografts, 2019-2026
Figure 51: Chinese Market for Soft Tissue Allografts, 2019-2026
Figure 52: Indian Market for Soft Tissue Allografts, 2019-2026
Figure 53: Australia and New Zealand’s Market for Soft Tissue Allografts, 2019-2026
Figure 54: Rest of Asia-Pacific Market for Soft Tissue Allografts, 2019-2026
Figure 55: Latin American Market Shares for Soft Tissue Allografts, by Product, 2020
Figure 56: Latin American Market Shares for Soft Tissue Allografts, by Application, 2020
Figure 57: Latin American Market Shares for Soft Tissue Allografts and Alternatives, by Country, 2020
Figure 58: Brazilian Market for Soft Tissue Allografts, 2019-2026
Figure 59: Argentinian Market for Soft Tissue Allografts, 2019-2026
Figure 60: Rest of Latin American Countries Market for Soft Tissue Allografts, 2019-2026
Figure 61: Middle Eastern & African Market Shares for Soft Tissue Allografts, by Product, 2020
Figure 62: Middle Eastern & African Market Shares for Soft Tissue Allografts, by Application, 2020
Figure 63: Middle Eastern & African Market Shares for Soft Tissue Allografts, by Country, 2020
Figure 64: GCC Countries Market for Soft Tissue Allografts, 2019-2026
Figure 65: South African Market for Soft Tissue Allografts, 2019-2026
Figure 66: Rest of Middle Eastern & African Countries Market for Soft Tissue Allografts, 2019-2026
Figure 67: Steep Reduction in Organ & Tissue Transplantation Seen During COVID-19
Figure 68: Market Shares of Major Players in the Soft Tissue Allograft, 2020
Figure 69: AlloSource Inc.: Annual Revenue, 2018-2020
Figure 70: Anika Therapeutics Inc.: Annual Revenue, 2016-2020
Figure 71: Anika Therapeutics Inc.: Revenue Shares, by Region/Country, 2020
Figure 72: Anika Therapeutics Inc.: Revenue Shares, by Business Unit, 2020
Figure 73: Johnson & Johnson: Annual Revenue, 2016-2020
Figure 74: Johnson & Johnson: Revenue Shares, by Region/Country, 2019
Figure 75: Johnson & Johnson: Revenue Shares, by Business Unit, 2019
Figure 76: Organogenesis Inc.: Annual Revenue, 2017-2020
Figure 77: Organogenesis Inc.: Revenue Shares by Products, 2020
Figure 78: Straumann Holding AG: Annual Revenue, 2017-2020
Figure 79: Straumann Holding AG: Revenue Shares, by Region/Country, 2020
Figure 80: Zimmer Biomet Holdings: Annual Revenue, 2016-2020
Figure 81: Zimmer Biomet Holdings: Revenue Shares, by Region, 2020
Figure 82: Zimmer Biomet Holdings: Revenue Shares, by Products, 2020

Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Allosource Inc.
  • Arthrex Inc.
  • Cook Medical Inc.
  • Johnson & Johnson
  • Organogenesis Inc.
  • Straumann Holding Ag.

The high growth rate of this segment is attributed to factors such as demand for soft tissue allografts for patients in the U.S., Europe and some Asian countries; a rise in chronic diseases such as diabetes, cancer, etc.; increase in the prevalence of anterior cruciate ligament reconstruction; increasing bone and musculoskeletal transplant program; expansion of sports medicine and spine/neurology; and significant use for treating prominent or life-threatening disorders caused due to accidents.

Reasons for Doing This Study

The objectives of this study are to provide in-depth analysis and forecast of the market for soft tissue allografts. The focus is on products and procedures used or under development for surgery, including techniques, therapies, drugs, and diagnostics. Additionally, a market analysis of soft tissue allografts for applications such as wound care, dentistry, and orthopedic replacement and reconstruction will be explored.

Soft tissue grafts can be used to improve the aesthetics of organs. For example, grafts are used to stop gum recession and improve the gum line. Soft tissue can be used to cover roots or develop gum tissue that is absent due to excessive gingival recession. Periodontal procedures such as soft tissue grafting stop further dental problems and gum recession while improving the look of gum tissues. A variety of bone grafting approaches are available to treat recession cases with significant root prominence and a deficient buccal plate. The selection of graft materials and case type may impact the ability to achieve complete regeneration of the periodontium. The extensiveness of the root prominence and recession and degree of buccal plate deficiency will impact graft material selection and clinical outcomes. A variety of materials have histologic evidence of complete regeneration with either recession or intrabody defect treatment, including PDGF-bb, enamel matrix derivatives (EMDs), an organic bovine-derived hydroxyapatite matrix, and freeze-dried bone allograft.

The report is designed to provide the reader with a background on the soft tissue allografts market and tools to make decisions regarding expansion and penetration in this market.

Note: Product cover images may vary from those shown
  • Allosource Inc.
  • Anika Therapeutics Inc.
  • Arthrex Inc.
  • Biohorizons Iph
  • Biotissue Technologies Gmbh
  • Cook Medical Inc.
  • Globus Medical Inc.
  • Integra Lifesciences Corp.
  • Johnson & Johnson
  • Mimedx Group Inc.
  • Organogenesis Inc.
  • Seaspine
  • Straumann Holding Ag.
  • Zimmer Biomet Holdings
Note: Product cover images may vary from those shown
Adroll
adroll